Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1930 1
1946 2
1947 1
1949 1
1950 1
1951 3
1952 4
1953 4
1954 2
1955 2
1956 2
1957 2
1958 3
1959 8
1960 1
1961 1
1962 2
1964 5
1965 1
1966 5
1967 7
1969 3
1970 4
1971 4
1972 11
1973 8
1974 1
1976 1
1977 2
1978 4
1979 5
1981 1
1982 4
1983 3
1984 3
1985 3
1986 1
1987 3
1988 7
1989 3
1990 3
1991 7
1992 4
1993 11
1994 10
1995 11
1996 4
1997 2
1998 4
1999 3
2000 7
2001 2
2002 8
2003 9
2004 14
2005 14
2006 10
2007 17
2008 21
2009 19
2010 23
2011 20
2012 32
2013 30
2014 34
2015 29
2016 25
2017 20
2018 33
2019 45
2020 40
2021 41
2022 38
2023 56
2024 46

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

741 results

Results by year

Filters applied: . Clear all
Page 1
LRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with Parkinson's Disease.
Jennings D, Huntwork-Rodriguez S, Vissers MFJM, Daryani VM, Diaz D, Goo MS, Chen JJ, Maciuca R, Fraser K, Mabrouk OS, van de Wetering de Rooij J, Heuberger JAAC, Groeneveld GJ, Borin MT, Cruz-Herranz A, Graham D, Scearce-Levie K, De Vicente J, Henry AG, Chin P, Ho C, Troyer MD. Jennings D, et al. Among authors: fraser k. Mov Disord. 2023 Mar;38(3):386-398. doi: 10.1002/mds.29297. Epub 2023 Feb 18. Mov Disord. 2023. PMID: 36807624 Clinical Trial.
Cooperative CAR targeting to selectively eliminate AML and minimize escape.
Haubner S, Mansilla-Soto J, Nataraj S, Kogel F, Chang Q, de Stanchina E, Lopez M, Ng MR, Fraser K, Subklewe M, Park JH, Wang X, Rivière I, Sadelain M. Haubner S, et al. Among authors: fraser k. Cancer Cell. 2023 Nov 13;41(11):1871-1891.e6. doi: 10.1016/j.ccell.2023.09.010. Epub 2023 Oct 5. Cancer Cell. 2023. PMID: 37802054 Free PMC article.
Trial of Cinpanemab in Early Parkinson's Disease.
Lang AE, Siderowf AD, Macklin EA, Poewe W, Brooks DJ, Fernandez HH, Rascol O, Giladi N, Stocchi F, Tanner CM, Postuma RB, Simon DK, Tolosa E, Mollenhauer B, Cedarbaum JM, Fraser K, Xiao J, Evans KC, Graham DL, Sapir I, Inra J, Hutchison RM, Yang M, Fox T, Budd Haeberlein S, Dam T; SPARK Investigators. Lang AE, et al. Among authors: fraser k. N Engl J Med. 2022 Aug 4;387(5):408-420. doi: 10.1056/NEJMoa2203395. N Engl J Med. 2022. PMID: 35921450 Clinical Trial.
Occasion setting.
Fraser KM, Holland PC. Fraser KM, et al. Behav Neurosci. 2019 Apr;133(2):145-175. doi: 10.1037/bne0000306. Behav Neurosci. 2019. PMID: 30907616 Free PMC article. Review.
Normalizing the environment recapitulates adult human immune traits in laboratory mice.
Beura LK, Hamilton SE, Bi K, Schenkel JM, Odumade OA, Casey KA, Thompson EA, Fraser KA, Rosato PC, Filali-Mouhim A, Sekaly RP, Jenkins MK, Vezys V, Haining WN, Jameson SC, Masopust D. Beura LK, et al. Among authors: fraser ka. Nature. 2016 Apr 28;532(7600):512-6. doi: 10.1038/nature17655. Epub 2016 Apr 20. Nature. 2016. PMID: 27096360 Free PMC article.
Case Management.
Fraser K. Fraser K. Prof Case Manag. 2020 Nov/Dec;25(6):350. doi: 10.1097/NCM.0000000000000468. Prof Case Manag. 2020. PMID: 33017372 No abstract available.
Designer DNA nanostructures for viral inhibition.
Ren S, Fraser K, Kuo L, Chauhan N, Adrian AT, Zhang F, Linhardt RJ, Kwon PS, Wang X. Ren S, et al. Among authors: fraser k. Nat Protoc. 2022 Feb;17(2):282-326. doi: 10.1038/s41596-021-00641-y. Epub 2022 Jan 10. Nat Protoc. 2022. PMID: 35013618 Free PMC article. Review.
741 results